Shilpa Medicare inks commercial supply deal with Orion for innovative recombinant human albumin
Under the terms of the agreement, Orion will gain exclusive rights to distribute, market and sell Shilpa’s recombinant human albumin in Europe, with Shilpa receiving development and regulatory milestone payments from Orion.
Albumin | 13/06/2025 | By Darshana | 127
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy